Smartwatches and rings that claim to measure blood sugar levels for medical purposes without piercing the skin could be dangerous and should be avoided, the U.S. Food and Drug Administration warned Wednesday.
Feb 22, 2024
0
1
Today's Food and Drug Administration approval of a supplemental biologics license for the monoclonal antibody omalizumab (Xolair) highlights the vital role of the National Institutes of Health-supported research that underpins ...
Feb 16, 2024
0
0
Aurlumyn (iloprost), a vasodilator, has been approved by the U.S. Food and Drug Administration to treat severe frostbite. The injected medication lowers the risk for finger or toe amputation.
Feb 15, 2024
0
0
A controversial Alzheimer's drug that was trumpeted as the first to ever treat the cognitive decline associated with the devastating brain disorder has been pulled from the market, its maker Biogen announced Wednesday.
Jan 31, 2024
0
15
Researchers at Hackensack Meridian's John Theurer Cancer Center (JTCC), are part of a published Phase 3 study reporting on the equivalent safety and effectiveness in the oral treatment of blood cancers–such as myelodysplastic ...
Jan 31, 2024
0
0
Reiterating a warning first issued in November, the U.S. Food and Drug Administration is urging Americans to stay away from supplements containing tianeptine, known on the street as "gas station heroin."
Jan 25, 2024
0
1
A new editorial paper titled "One more step toward treatment of PARP inhibitor-resistant ovarian cancers" has been published in Oncotarget.
Jan 10, 2024
0
2
Many physicians are unfamiliar with how the Food and Drug Administration's (FDA) regulates new drugs and medical devices, and they may be under the impression that the data supporting these approvals are more rigorous than ...
Jan 9, 2024
0
0
In 2003, the first year of her fellowship in pediatric oncology, two of Giselle Saulnier Sholler's first three patients had died from neuroblastoma, closely matching the 30% survival rate expected at the time for high-risk ...
Dec 15, 2023
0
16
A new Northwestern University study—led by Bernard Black of Northwestern's Pritzker School of Law and Kellogg School of Management—suggests that the U.S. could have saved many lives by authorizing a COVID-19 booster dose ...
Dec 5, 2023
0
2
